In vivo analysis of the molecular genetics of acute promyelocytic leukemia

被引:44
作者
Pandolfi, PP [1 ]
机构
[1] Cornell Univ, Program Mol Biol, Dept Pathol, Sloan Kettering Div,Grad Sch Med Sci, New York, NY 10021 USA
关键词
APL; cancer; transgenic mice; KO mice; animal models; transcription factors;
D O I
10.1038/sj.onc.1204600
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute promyelocytic leukemia (APL) is a distinct and paradigmatic subtype of myeloid leukemia associated with reciprocal chromosomal translocations always involving the Retinoic Acid Receptor alpha (RAR alpha) gene on chromosome 17 and variable partner genes (X genes) on different chromosomes. As a consequence of these translocations X-RAR alpha and RAR alpha -X fusion genes are generated. RAR alpha fuses to the PML gene in the vast majority of APL cases, and in a few cases to the PLZF, NPM, NuMA and STAT5b genes respectively. In the last few years, the functions of these aberrant fusion proteins and of the normal gene products involved in these translocations have been extensively characterized in vivo in transgenic and KO animal models. Here we will review the important conclusions, the novel questions and paradoxes that stem from this analysis.
引用
收藏
页码:5726 / 5735
页数:10
相关论文
共 58 条
  • [51] The RAR alpha-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain
    Sitterlin, D
    Tiollais, P
    Transy, C
    [J]. ONCOGENE, 1997, 14 (09) : 1067 - 1074
  • [52] RETINOIDS IN CANCER-THERAPY
    SMITH, MA
    PARKINSON, DR
    CHESON, BD
    FRIEDMAN, MA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (05) : 839 - 864
  • [53] Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
    Soignet, SL
    Maslak, P
    Wang, ZG
    Jhanwar, S
    Calleja, E
    Dardashti, LJ
    Corso, D
    DeBlasio, A
    Gabrilove, J
    Scheinberg, DA
    Pandolfi, PP
    Warrell, RP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (19) : 1341 - 1348
  • [54] Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
    Warrell, RP
    He, LZ
    Richon, V
    Calleja, E
    Pandolfi, PP
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (21): : 1621 - 1625
  • [55] Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia
    Wells, RA
    Catzavelos, C
    KamelReid, S
    [J]. NATURE GENETICS, 1997, 17 (01) : 109 - 113
  • [56] The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases
    Wu, WS
    Vallian, S
    Seto, E
    Yang, WM
    Edmondson, D
    Roth, S
    Chang, KS
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (07) : 2259 - 2268
  • [57] Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice
    Zimonjic, DB
    Pollock, JL
    Westervelt, P
    Popescu, NC
    Ley, TJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) : 13306 - 13311
  • [58] A role for PML and the nuclear body in genomic stability
    Zong, S
    Hu, P
    Ye, TZ
    Stan, R
    Ellis, NA
    Pandolfi, PP
    [J]. ONCOGENE, 1999, 18 (56) : 7941 - 7947